Nephros director Amron acquires 3,514 shares

Available on EDGAR 11/12/2026 - 04:33 PM EST Accepted by SEC EDGAR 11/12/2026 - 04:32 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

Nephros Inc. (NEPH) director Arthur H. Amron acquired 3,514 common shares on November 9, 2026, issued in lieu of cash fees for board service. His direct common-stock holdings after the award were 162,137 shares. Amron also reported 25,546 shares held indirectly through Amron Holdings LLC, over which he has voting and dispositive power.

Insider Trade Summary

Grant/Award: 3,514 shares

Grant/Award 1 txn

Insider Amron Arthur H

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock F1	3,514	$0.00	$0.00
Holding	Stock Option (Right to Buy) F3	--	--	--
Holding	Stock Option (Right to Buy) F4	--	--	--
Holding	Common Stock F2	--	--	--

Holdings After Transaction: Common Stock — 162,137 shares (Direct); Stock Option (Right to Buy) — 14,373 options (Direct); Common Stock — 25,546 shares (Indirect, By Amron Holdings LLC)

Holdings Before and After: Common Stock, 158,623 to 162,137 shares (Direct)

Footnotes (4)

1. F1. Shares issued to the Reporting Person in lieu of cash fees for board service.
2. F2. Held by Amron Holdings LLC, over which the Reporting Person has voting and dispositive power as its controlling person.
3. F3. Fully vested.
4. F4. This option vests as to 2,350 shares on each of 1/1/25, 1/1/26 and 1/1/27.

Key Figures

Shares acquired: 3,514 common shares Direct common shares following award: 162,137 shares Indirect common shares: 25,546 shares +4 more

7 metrics

Shares acquired 3,514 common shares Issued in lieu of cash fees for board service on November 9, 2026

Direct common shares following award 162,137 shares Arthur H. Amron's direct holdings following the November 9, 2026 award

Indirect common shares 25,546 shares Held through Amron Holdings LLC

Fully vested option shares 7,323 underlying common shares Exercise price $2.13 per share; expires May 14, 2034

Fully vested option exercise price $2.13 per share Option covering 7,323 underlying common shares; expires May 14, 2034

Option shares with vesting installments 7,050 underlying common shares Exercise price $1.47 per share; expires January 1, 2035; vests in 2,350-share installments on January 1, 2025, January 1, 2026 and January 1, 2027

Option exercise price $1.47 per share Option covering 7,050 underlying common shares; expires January 1, 2035

Key Terms

Stock Option (Right to Buy), Fully vested, voting and dispositive power

3 terms

Stock Option (Right to Buy) technical

"Stock Option (Right to Buy) covering 7,323 underlying common shares"

Fully vested technical

"The option is fully vested"

voting and dispositive power regulatory

"Amron has voting and dispositive power over Amron Holdings LLC shares"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many NEPH shares did director Arthur H. Amron receive?

Arthur H. Amron acquired 3,514 common shares on November 9, 2026, issued in lieu of cash fees for board service.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Amron Arthur H

(Last) (First) (Middle)

C/O NEPHROS, INC., 380 LACKAWANNA PLACE

(Street)

SOUTH ORANGE NEW JERSEY 07079

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
NEPHROS INC [ NEPH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
11/09/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	11/09/2026		A		3,514(1)	A	$0	162,137	D
Common Stock								25,546	I	By Amron Holdings LLC(2)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$2.13							(3)	05/14/2034	Common Stock	7,323		7,323	D
Stock Option (Right to Buy)	$1.47							(4)	01/01/2035	Common Stock	7,050		7,050	D

Explanation of Responses:

1. Shares issued to the Reporting Person in lieu of cash fees for board service.

2. Held by Amron Holdings LLC, over which the Reporting Person has voting and dispositive power as its controlling person.

3. Fully vested.

4. This option vests as to 2,350 shares on each of 1/1/25, 1/1/26 and 1/1/27.

	/s/ Arthur H. Amron	11/12/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)